Maintenance therapy is typically considered for cancers that are prone to relapse or progression after initial treatment. This includes cancers like non-small cell lung cancer, certain types of lymphoma, and multiple myeloma. The decision to use maintenance therapy depends on several factors, such as the type of cancer, its stage, the patient's overall health, and the response to initial treatment.
